New York State Common Retirement Fund Rubius Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$0.79 - $5.98 $22,436 - $169,832	-28,400 Reduced 98.52%	426 $0
Q1 2022 May 05, 2022	SELL	$4.25 - $10.4 $19,418 - $47,517	-4,569 Reduced 13.68%	28,826 $159,000
Q4 2021 Feb 02, 2022	SELL	$9.68 - $17.74 $14,365 - $26,326	-1,484 Reduced 4.25%	33,395 $323,000
Q3 2021 Nov 02, 2021	SELL	$17.6 - $25.91 $70,822 - $104,261	-4,024 Reduced 10.34%	34,879 $624,000
Q2 2021 Aug 02, 2021	BUY	$22.26 - $28.43 $158,112 - $201,938	7,103 Added 22.34%	38,903 $950,000
Q1 2021 May 11, 2021	BUY	$8.02 - $32.01 $40,902 - $163,251	5,100 Added 19.1%	31,800 $843,000
Q4 2019 Feb 05, 2020	SELL	$7.23 - $14.12 $66,516 - $129,904	-9,200 Reduced 25.63%	26,700 $254,000
Q2 2019 Aug 09, 2019	BUY	$13.5 - $19.94 $387,450 - $572,278	28,700 Added 398.61%	35,900 $565,000
Q4 2018 Feb 08, 2019	BUY	$13.83 - $22.97 $99,576 - $165,384	7,200 New	7,200 $116,000

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.